Opportunity Information: Apply for RFA HG 23 025
This funding opportunity (RFA-HG-23-025) is a National Institutes of Health (NIH) cooperative agreement from the National Human Genome Research Institute (NHGRI) to stand up and run the Human Pangenome Coordinating Center (HPCC) under the renewed Human Genome Reference Program (HGRP). The HPCC is positioned as the central hub for the entire program, meaning it is expected to coordinate both the day-to-day logistics and the scientific integration across HGRP activities. A major deliverable is the ongoing creation, improvement, public release, and long-term maintenance of new versions of the human pangenome reference. The overarching purpose of the HGRP renewal is to produce a pangenome reference that better captures population genetic diversity while also being practical and attractive enough that the broader genomics research community will actually use it, build tools around it, and adopt it as a standard reference resource. Clinical trials are not allowed under this opportunity.
The award mechanism is a U41 cooperative agreement, which signals substantial NIH involvement compared with a standard research grant. In practical terms, applicants should expect active collaboration with NHGRI program staff, shared governance expectations, and milestone-driven coordination typical of large community resource efforts. The activity category is Health (CFDA 93.172), and the opportunity is listed as discretionary funding. While an award ceiling and expected number of awards are not specified in the provided notice, the scope implies a sizable, program-level coordinating function rather than a small, single-lab project.
Eligibility is restricted because this is a limited competition request for applications (RFA). Only organizations that were recipients under the earlier funding announcement RFA-HG-19-004 are eligible to apply, which narrows the pool to prior HGRP awardees. Within that constraint, the notice also lists a broad set of organizational types that NIH typically recognizes as eligible applicants, including various levels of U.S. government entities, public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses. It additionally calls out categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, Historically Black Colleges and Universities, tribally controlled colleges and universities, tribal governments and tribal organizations, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions. The key takeaway is that the competition is limited by prior participation (RFA-HG-19-004), even though the general NIH applicant types are described broadly.
Foreign participation rules are specific. Non-U.S. institutions (foreign institutions) are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply as applicant components. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which usually means a U.S.-led application can include defined project components performed abroad when they are well-justified and appropriately structured, even though the applicant organization itself must be eligible and based in the U.S.
Key dates from the listing include a creation date of June 20, 2023, and an original application due date of August 15, 2023. The funding instrument type is explicitly a cooperative agreement, reinforcing that the HPCC is expected to function as a community-facing infrastructure and coordination resource that helps deliver a usable, widely adopted human pangenome reference through regular updates, releases, and maintenance aligned with NHGRI goals for diversity representation and utility.Apply for RFA HG 23 025
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
- This funding opportunity was created on 2023-06-20.
- Applicants must submit their applications by 2023-08-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the funding opportunity number and title?
This opportunity is RFA-HG-23-025. It supports standing up and running the Human Pangenome Coordinating Center (HPCC) under the renewed Human Genome Reference Program (HGRP).
Which agency and NIH institute are sponsoring this opportunity?
The opportunity is sponsored by the National Institutes of Health (NIH), specifically the National Human Genome Research Institute (NHGRI).
What is being funded under this announcement?
The award supports the HPCC as the central hub for the renewed HGRP. The HPCC is expected to coordinate day-to-day program logistics and enable scientific integration across HGRP activities.
What is the role of the Human Pangenome Coordinating Center (HPCC) within HGRP?
The HPCC is positioned as the program-wide coordination hub. It is expected to handle ongoing coordination and integration across the program rather than operating as a single stand-alone research project.
What are the major deliverables for the HPCC?
A major deliverable is the ongoing creation, improvement, public release, and long-term maintenance of new versions of the human pangenome reference.
What is the overall purpose of the renewed Human Genome Reference Program (HGRP)?
The renewal aims to produce a human pangenome reference that better captures population genetic diversity and is practical and attractive enough for broad adoption by the genomics research community as a standard reference resource.
Why does the opportunity emphasize adoption by the broader genomics community?
The stated goal is not only to improve diversity representation in the reference, but also to make the resource usable enough that researchers will actually use it, build tools around it, and adopt it as a standard.
Are clinical trials allowed under this opportunity?
No. Clinical trials are not allowed under this funding opportunity.
What is the award mechanism?
The award mechanism is a U41 cooperative agreement.
What does it mean that this is a cooperative agreement (U41)?
A cooperative agreement indicates substantial NIH involvement compared with a standard research grant. Applicants should expect active collaboration with NHGRI program staff, shared governance expectations, and milestone-driven coordination typical of large community resource efforts.
What is the funding instrument type?
The funding instrument type is a cooperative agreement, aligning with the HPCC being a community-facing infrastructure and coordination resource.
What is the activity category and CFDA listing?
The activity category is Health, and it is associated with CFDA 93.172.
Is this discretionary funding?
Yes. The listing identifies this opportunity as discretionary funding.
Is there an award ceiling or an expected number of awards stated?
No. The provided notice does not specify an award ceiling or an expected number of awards.
What does the scope suggest about the size or nature of the award?
While no dollar ceiling is provided, the scope suggests a sizable, program-level coordinating function rather than a small, single-lab project.
Is this a limited competition?
Yes. This is a limited competition request for applications (RFA).
Who is eligible to apply?
Eligibility is restricted to organizations that were recipients under the earlier funding announcement RFA-HG-19-004 (prior HGRP awardees).
If many organization types are listed as eligible, does that mean any of them can apply?
No. Even though the notice lists many organization types NIH commonly recognizes, the key restriction is that only prior recipients under RFA-HG-19-004 are eligible to apply.
What kinds of organization types are mentioned in the eligibility description?
Within the limited-competition constraint, the notice lists a broad range of organization types NIH typically recognizes, including U.S. federal/state/local/tribal government entities, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses. It also calls out serving institutions and community-based categories such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, tribal governments and organizations, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions.
Can a foreign institution apply as the primary applicant?
No. Non-U.S. institutions (foreign institutions) are not eligible to apply as the primary applicant organization.
Can a non-domestic component of a U.S. organization apply as an applicant component?
No. Non-domestic components of U.S. organizations are not eligible to apply as applicant components.
Are foreign components allowed in an otherwise eligible application?
Yes. Foreign components are allowed as defined in the NIH Grants Policy Statement, meaning a U.S.-led application can include well-justified project components performed abroad when structured appropriately.
What is the HPCC expected to coordinate?
The HPCC is expected to coordinate both day-to-day logistics and scientific integration across HGRP activities, acting as a central program hub.
How is the human pangenome reference expected to be managed over time?
The opportunity calls for ongoing creation, improvement, public release, and long-term maintenance of new versions of the reference, implying regular updates and sustained stewardship aligned with NHGRI goals.
When was this opportunity created and what was the application due date?
The listing shows a creation date of June 20, 2023, and an original application due date of August 15, 2023.
Browse more opportunities from the same category: Health
Next opportunity: BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
Previous opportunity: Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HG 23 025
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HG 23 025) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed) Apply for RFA HG 23 024 Funding Number: RFA HG 23 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) Apply for PAR 24 210 Funding Number: PAR 24 210 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) Apply for RFA HG 23 026 Funding Number: RFA HG 23 026 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed) Apply for PAR 23 195 Funding Number: PAR 23 195 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed) Apply for RFA HG 23 027 Funding Number: RFA HG 23 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for RFA OD 23 019 Funding Number: RFA OD 23 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36) Apply for RFA OD 23 020 Funding Number: RFA OD 23 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) Apply for PAR 23 200 Funding Number: PAR 23 200 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed) Apply for PAR 23 205 Funding Number: PAR 23 205 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed) Apply for RFA NS 24 009 Funding Number: RFA NS 24 009 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed) Apply for RFA NS 24 025 Funding Number: RFA NS 24 025 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) Apply for PAR 23 225 Funding Number: PAR 23 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 23 215 Funding Number: PAR 23 215 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) Apply for PA 23 189 Funding Number: PA 23 189 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed) Apply for RFA AI 23 039 Funding Number: RFA AI 23 039 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) Apply for PAR 24 023 Funding Number: PAR 24 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed) Apply for RFA MH 24 100 Funding Number: RFA MH 24 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Youth Violence Prevention Interventions (R01 - Clinical Trial Required) Apply for RFA MD 24 002 Funding Number: RFA MD 24 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) Apply for PAR 24 026 Funding Number: PAR 24 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed) Apply for PAR 23 234 Funding Number: PAR 23 234 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 23 025", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.